Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing ...
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...
Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a listed discovery-based and market-focused ...
Walt Disney Co. is investing $1 billion in OpenAI under a new commercial partnership with the ChatGPT and Sora developer. The three-year licensing agreement will allow users of Sora, OpenAI's ...
CALGARY, Alberta, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) today announced that it has entered into a multi-year software licensing agreement ...
Apple’s latest iPhone software is iOS 26. Released in mid-September, it was followed by a small bug-fix update in the form of iOS 26.0.1. Now, there’s the first major update, with new features as well ...
An update from Phoenix New Media ( (FENG)) is now available. On November 5, 2025, Phoenix New Media Limited announced a new program license agreement with Phoenix Satellite Television Holdings Limited ...
EMERYVILLE, Calif. and SOUTH SAN FRANCISCO, Calif., Nov. 5, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and ...
A bit later in the day than normal, Apple has moved on to its fifth round of developer betas and probably the last one for iOS 26.1, iPadOS 26.1, macOS 26.1 Tahoe, watchOS 26.1, tvOS 26.1, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback